Go to Top

Iproteos, from protein-protein interactions to peptide drugs

The company focuses its activity on the Research and Development of new therapeutic strategies based on modulation of protein-ligand (PLI) and protein-protein interactions (PPIs) through non-natural peptides or peptidomimetics. The novel entitties are obtained thanks to the IPRO technology, an innovative platform.

Specifically, at Iproteos we apply the IPRO technology on the search for therapeutic agents for the treatment of diseases of the central nervous system (CNS).

Furthermore, we seek for partners that are interested on the implementation of the IPRO technology to their biotechnology or pharmaceutical companies.


Iproteos is continuously expanding its partner and collaborator network in order to maximize the scientific and financial support.